For the first time, our results demonstrate a significant decrease in PSA-NCAM and ST8Sia4 protein expression following Aβ treatment, establishing a mechanistic link between Aβ-induced reductions in PSA-NCAM and impaired ST8Sia4 activity in AD. Here, PROS1 is linked to Alzheimer disease.